Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001416041-07-000002
Filing Date
2007-11-16
Accepted
2007-11-16 18:49:48
Documents
2
Period of Report
2007-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 3  
1 PRIMARY DOCUMENT edgardoc.xml 3 2048
2 EDGAR SUPPORTING DOCUMENT poa-belle.txt EX-24 3239
  Complete submission text file 0001416041-07-000002.txt   7036
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 801-584-3672
Belle Gerald P. (Reporting) CIK: 0001416041 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26642 | Film No.: 071254543